BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 16, 2008
View Archived Issues
Novel agents for asthma and other respiratory disorders reported in recent patents
Read More
Enhanced effects seen with combination of radiotherapy and AZD-6244 in lung cancer model
Read More
Experiments with caprospinol reveal potentially useful effects against Alzheimer's disease
Read More
Arete describes new antihypertensive agents in a recent patent
Read More
Recent GSK, Ranbaxy and Schering patents disclose novel antimicrobial agents
Read More
Beneficial effects of iNOS inhibitors demonstrated in experimental COPD
Read More
URL submits NDA to the FDA for colchicine tablets in gout flares
Read More
MJFF awards USD 2 million grant to research projects on cognitive deficits in PD
Read More
FDA to review Arpida's NDA for iclaprim in cSSSI in November 2008
Read More
Synta receives USD 25 million milestone payment from GSK under elesclomol collaboration
Read More
RXi licenses rights from UMMS to technology for oral delivery of RNAi therapeutics
Read More
Lilly initiates cash tender offer for ImClone at USD 70 per share
Read More
Aradigm completes enrollment in phase II study of inhaled liposomal ciprofloxacin
Read More
Regado completes enrollment in REVERSAL-PCI phase IIa clinical study of REG1
Read More
Inhibiting FtsZ protein shows potential anti-staphylococcal activity in experimental model
Read More
Addex completes the first part of a two-part phase I ADX-48621 trial
Read More
Akorn launches Akten Gel 3.5% as a topical ocular anesthetic
Read More
Almirall and Forest to progress the development of aclidinium bromide
Read More
Avigen initiates exploratory study of AV-411 in opioid withdrawal
Read More
ChemoCentryx advances oral CCR9 antagonist CCX-025 into the clinic
Read More
BioMarin presents phase IIa results for 6R-BH4 in sickle cell disease
Read More
Palifosfamide receives positive opinion for E.U. orphan product designation
Read More
Sirion launches Durezol for postoperative ocular inflammation and pain
Read More
R&D highlights from the UBS Global Life Sciences Conference in New York: Oxford BioMedica
Read More
Lapatinib shows encouraging activity in phase II SCCHN study
Read More